<PAGE>   1
              As filed with the Securities and Exchange Commission
                              on February 11, 1998.

                                                 Registration No. 333- _________

--------------------------------------------------------------------------------

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM S-8

             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

                             WANG LABORATORIES, INC.
               (Exact name of issuer as specified in its charter)

                   DELAWARE                                     04-2192707
       (State or other jurisdiction of                       (I.R.S. Employer
        incorporation or organization)                    Identification Number)

         600 TECHNOLOGY PARK DRIVE                                 01821
          BILLERICA, MASSACHUSETTS
  (Address of Principal Executive Offices)                       (Zip Code)

                         1995 DIRECTOR STOCK OPTION PLAN
                            (Full title of the Plan)

                             ALBERT A. NOTINI, ESQ.
                             WANG LABORATORIES, INC.
                            600 TECHNOLOGY PARK DRIVE
                         BILLERICA, MASSACHUSETTS 01821
                     (Name and address of agent for service)

                                 (978) 967-5000
          (Telephone number, including area code, of agent for service)

<TABLE>
---------------------------------------------------------------------------------------
                         CALCULATION OF REGISTRATION FEE

<CAPTION>
                                Proposed 
Title of          Amount        maximum           Proposed maximum
securities to     to be         offering price    aggregate            Amount of 
be registered     registered    per share         offering price       registration fee
-------------     ----------    ---------         --------------       ----------------
<S>               <C>           <C>               <C>                  <C>
Common Stock,
$.01 par value    60,000        $25.50(1)         $1,530,000(1)        $451.35
per share         shares
---------------------------------------------------------------------------------------
</TABLE>

(1)  Estimated solely for the purpose of calculating the registration fee, and
     based upon the average of the high and low prices of the Registrant's
     Common Stock on the NASDAQ National Market on February 9, 1998 in
     accordance with Rule 457(c) and 457(h) of the Securities Act of 1933.

--------------------------------------------------------------------------------


<PAGE>   2

                    STATEMENT OF INCORPORATION BY REFERENCE

     This Registration Statement on Form S-8 incorporates by reference the
contents of the Registration Statement on Form S-8, File No. 33-89910, filed by
the Registrant on March 2, 1995 relating to the Registrant's 1995 Director Stock
Option Plan.


<PAGE>   3


                                   SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the Town of Billerica, Commonwealth of Massachusetts, on this
10th day of February, 1998


                                      WANG LABORATORIES, INC.



                                      By:   /s/ Franklyn A. Caine
                                          --------------------------------------
                                          Franklyn A. Caine
                                          Executive Vice President and
                                            Chief Financial Officer


                                POWER OF ATTORNEY


     We, the undersigned officers and directors of Wang Laboratories, Inc.
hereby severally constitute Albert A. Notini and John A. Burgess, and each of
them singly, our true and lawful attorneys with full power to them, and each of
them singly, to sign for us and in our names in the capacities indicated below,
the Registration Statement on Form S-8 filed herewith and any and all subsequent
amendments to said Registration Statement, and generally to do all such things
in our names and behalf in our capacities as officers and directors to enable
Wang Laboratories, Inc. to comply with all requirements of the Securities and
Exchange Commission, hereby ratifying and confirming our signatures as they may
be signed by said attorneys, or any of them, to said Registration Statement and
any and all amendments thereto.

     Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated:

Signature                 Title                                      Date
---------                 -----                                      ----
                                                            
/s/ Joseph M. Tucci       Chairman of the Board, Chief         February 10, 1998
----------------------    Executive Officer and Director    
Joseph M. Tucci           (Principal Executive Officer)     
                                                            
/s/ Franklyn A. Caine     Executive Vice President and Chief   February 10, 1998
----------------------    Financial Officer                 
Franklyn A. Caine         (Principal Financial Officer and  
                          Accounting Officer)               
                                                            
                                                            
/s/ David A. Boucher      Director                             February 10, 1998
----------------------                                      
David A. Boucher                                            
                                                            
                                                            
/s/ Michael W. Brown      Director                             February 10, 1998
----------------------                                      
Michael W. Brown                                            
                                                            
                                                            
/s/ Marcia J. Hooper      Director                             February 10, 1998
----------------------                                      
Marcia J. Hooper     
                   



<PAGE>   4

Signature                 Title                           Date
---------                 -----                           ----


/s/ Joseph J. Kroger       Director                  February 10, 1998
--------------------
Joseph J. Kroger


/s/ Raymond C. Kurzweil    Director                  February 10, 1998
--------------------
Raymond C. Kurzweil


                           Director                  
--------------------
Axel J. Leblois

 
/s/ Frederick A. Wang      Director                  February 10, 1998
--------------------
Frederick A. Wang


/s/ John P. White          Director                  February 10, 1998
--------------------
John P. White
<PAGE>   5


                                  EXHIBIT INDEX

4.1*    Certificate of Incorporation of the Registrant

4.2**   By-Laws of the Registrant, as amended to date

5.1     Opinion of Hale & Dorr LLP

23.1    Consent of Hale & Dorr LLP (included in Exhibit 5.1)

23.2    Consent of Ernst & Young, LLP

24.1    Power of Attorney (included on page 3 of the Registration Statement)


-----------------

*    Filed as an Exhibit to the Registrant's quarterly report on 10-Q for the
     quarter ended December 31, 1994 and incorporated herein by reference.

**   Filed as an Exhibit to the Registrant's quarterly report on 10-Q for the
     quarter ended December 31, 1995 and incorporated herein by reference.
[{"type": "S-8", "sequence": "1", "description": "WANG LABORATORIES, INC.", "secsgml_size_bytes": 8125}]
{"company-data": {"conformed-name": "WANG LABORATORIES INC", "cik": "0000104519", "assigned-sic": "7372", "irs-number": "042192707", "state-of-incorporation": "DE", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-46081", "film-number": "98532262"}, "business-address": {"street1": "600 TECHNOLOGY PARK DRIVE", "city": "BILLERICA", "state": "MA", "zip": "01821-4120", "phone": "5089675000"}, "mail-address": {"street1": "600 TECHNOLOGY PARK DRIVE", "street2": "MAILSTOP 014-B3C", "city": "BILLERICA", "state": "MA", "zip": "01821-4120"}}
1
              As filed with the Securities and Exchange Commission
                              on February 11, 1998.

                                                 Registration No. 333- _________

--------------------------------------------------------------------------------

                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM S-8

             REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933

                             WANG LABORATORIES, INC.
               (Exact name of issuer as specified in its charter)

                   DELAWARE                                     04-2192707
       (State or other jurisdiction of                       (I.R.S. Employer
        incorporation or organization)                    Identification Number)

         600 TECHNOLOGY PARK DRIVE                                 01821
          BILLERICA, MASSACHUSETTS
  (Address of Principal Executive Offices)                       (Zip Code)

                         1995 DIRECTOR STOCK OPTION PLAN
                            (Full title of the Plan)

                             ALBERT A. NOTINI, ESQ.
                             WANG LABORATORIES, INC.
                            600 TECHNOLOGY PARK DRIVE
                         BILLERICA, MASSACHUSETTS 01821
                     (Name and address of agent for service)

                                 (978) 967-5000
          (Telephone number, including area code, of agent for service)

---------------------------------------------------------------------------------------
                         CALCULATION OF REGISTRATION FEE
Proposed 
Title of          Amount        maximum           Proposed maximum
securities to     to be         offering price    aggregate            Amount of 
be registered     registered    per share         offering price       registration fee
-------------     ----------    ---------         --------------       ----------------
Common Stock,
$.01 par value    60,000        $25.50(1)         $1,530,000(1)        $451.35
per share         shares
---------------------------------------------------------------------------------------
(1)  Estimated solely for the purpose of calculating the registration fee, and
     based upon the average of the high and low prices of the Registrant's
     Common Stock on the NASDAQ National Market on February 9, 1998 in
     accordance with Rule 457(c) and 457(h) of the Securities Act of 1933.

--------------------------------------------------------------------------------
2

                    STATEMENT OF INCORPORATION BY REFERENCE

     This Registration Statement on Form S-8 incorporates by reference the
contents of the Registration Statement on Form S-8, File No. 33-89910, filed by
the Registrant on March 2, 1995 relating to the Registrant's 1995 Director Stock
Option Plan.
3

                                   SIGNATURES

     Pursuant to the requirements of the Securities Act of 1933, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-8 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the Town of Billerica, Commonwealth of Massachusetts, on this
10th day of February, 1998

                                      WANG LABORATORIES, INC.

                                      By:   /s/ Franklyn A. Caine
                                          --------------------------------------
                                          Franklyn A. Caine
                                          Executive Vice President and
                                            Chief Financial Officer

                                POWER OF ATTORNEY

     We, the undersigned officers and directors of Wang Laboratories, Inc.
hereby severally constitute Albert A. Notini and John A. Burgess, and each of
them singly, our true and lawful attorneys with full power to them, and each of
them singly, to sign for us and in our names in the capacities indicated below,
the Registration Statement on Form S-8 filed herewith and any and all subsequent
amendments to said Registration Statement, and generally to do all such things
in our names and behalf in our capacities as officers and directors to enable
Wang Laboratories, Inc. to comply with all requirements of the Securities and
Exchange Commission, hereby ratifying and confirming our signatures as they may
be signed by said attorneys, or any of them, to said Registration Statement and
any and all amendments thereto.

     Pursuant to the requirements of the Securities Act of 1933, this
Registration Statement has been signed by the following persons in the
capacities and on the dates indicated:

Signature                 Title                                      Date
---------                 -----                                      ----
                                                            
/s/ Joseph M. Tucci       Chairman of the Board, Chief         February 10, 1998
----------------------    Executive Officer and Director    
Joseph M. Tucci           (Principal Executive Officer)     
                                                            
/s/ Franklyn A. Caine     Executive Vice President and Chief   February 10, 1998
----------------------    Financial Officer                 
Franklyn A. Caine         (Principal Financial Officer and  
                          Accounting Officer)               
                                                            
                                                            
/s/ David A. Boucher      Director                             February 10, 1998
----------------------                                      
David A. Boucher                                            
                                                            
                                                            
/s/ Michael W. Brown      Director                             February 10, 1998
----------------------                                      
Michael W. Brown                                            
                                                            
                                                            
/s/ Marcia J. Hooper      Director                             February 10, 1998
----------------------                                      
Marcia J. Hooper
4

Signature                 Title                           Date
---------                 -----                           ----

/s/ Joseph J. Kroger       Director                  February 10, 1998
--------------------
Joseph J. Kroger

/s/ Raymond C. Kurzweil    Director                  February 10, 1998
--------------------
Raymond C. Kurzweil

                           Director                  
--------------------
Axel J. Leblois

 
/s/ Frederick A. Wang      Director                  February 10, 1998
--------------------
Frederick A. Wang

/s/ John P. White          Director                  February 10, 1998
--------------------
John P. White
5

                                  EXHIBIT INDEX

4.1*    Certificate of Incorporation of the Registrant

4.2**   By-Laws of the Registrant, as amended to date

5.1     Opinion of Hale & Dorr LLP

23.1    Consent of Hale & Dorr LLP (included in Exhibit 5.1)

23.2    Consent of Ernst & Young, LLP

24.1    Power of Attorney (included on page 3 of the Registration Statement)

-----------------

*    Filed as an Exhibit to the Registrant's quarterly report on 10-Q for the
     quarter ended December 31, 1994 and incorporated herein by reference.

**   Filed as an Exhibit to the Registrant's quarterly report on 10-Q for the
     quarter ended December 31, 1995 and incorporated herein by reference.